Header Logo

LINA MERJANEH

Concepts (65)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
4
2023
267
1.690
 Why?
Hyperglycemia
2
2023
233
1.240
 Why?
Vomiting
1
2021
104
0.660
 Why?
Autoantibodies
1
2022
439
0.600
 Why?
Polycystic Ovary Syndrome
1
2019
63
0.570
 Why?
Disease Progression
3
2023
2212
0.520
 Why?
Diabetes Mellitus, Type 2
4
2024
1429
0.470
 Why?
Hypopituitarism
1
2015
18
0.460
 Why?
Shock
1
2015
94
0.430
 Why?
Diabetes Mellitus
1
2022
895
0.430
 Why?
Prediabetic State
1
2014
67
0.400
 Why?
Gastroenteritis
1
2015
308
0.390
 Why?
Insulin-Secreting Cells
1
2014
136
0.390
 Why?
Diabetes Mellitus, Type 1
3
2024
877
0.310
 Why?
Glucose Tolerance Test
2
2020
199
0.260
 Why?
Adolescent
8
2024
20817
0.240
 Why?
Acute Disease
2
2020
1153
0.220
 Why?
Young Adult
6
2024
10016
0.220
 Why?
Insulin
2
2022
1146
0.210
 Why?
Blood Glucose Self-Monitoring
1
2023
128
0.190
 Why?
Hypoglycemia
1
2022
183
0.170
 Why?
Diabetic Ketoacidosis
1
2022
164
0.160
 Why?
Menstruation Disturbances
1
2019
16
0.150
 Why?
Hyperandrogenism
1
2019
19
0.150
 Why?
Child
5
2024
26220
0.150
 Why?
Vascular Stiffness
1
2020
82
0.150
 Why?
Blood Glucose
1
2023
1107
0.140
 Why?
Glucose
1
2023
853
0.140
 Why?
Monitoring, Physiologic
1
2020
373
0.140
 Why?
Humans
11
2024
130980
0.140
 Why?
Cholesterol, LDL
1
2020
615
0.120
 Why?
Combined Modality Therapy
1
2019
1241
0.120
 Why?
Thyroid Hormones
1
2015
54
0.110
 Why?
Hydrocortisone
1
2015
216
0.110
 Why?
Cardiovascular Diseases
2
2024
2100
0.100
 Why?
Diagnosis, Differential
1
2019
1896
0.100
 Why?
Glucose Intolerance
1
2014
80
0.100
 Why?
Prevalence
1
2020
2692
0.100
 Why?
Male
5
2024
64783
0.100
 Why?
Statistics, Nonparametric
1
2014
428
0.100
 Why?
Reference Values
1
2014
680
0.100
 Why?
Hormone Replacement Therapy
1
2015
214
0.090
 Why?
Practice Guidelines as Topic
1
2019
1298
0.090
 Why?
Time Factors
1
2022
6231
0.090
 Why?
Incidence
2
2024
3360
0.090
 Why?
Age Factors
2
2020
2851
0.090
 Why?
Cross-Sectional Studies
2
2022
3825
0.080
 Why?
Sex Factors
1
2014
1336
0.080
 Why?
Adult
3
2023
31296
0.080
 Why?
Pediatrics
1
2019
1245
0.080
 Why?
Comorbidity
1
2014
1598
0.070
 Why?
Female
4
2024
70723
0.070
 Why?
Risk Assessment
1
2014
3717
0.050
 Why?
Prognosis
1
2014
4950
0.050
 Why?
Forced Expiratory Volume
1
2023
178
0.050
 Why?
Adrenal Cortex Hormones
1
2023
333
0.040
 Why?
Diabetic Angiopathies
1
2020
67
0.040
 Why?
Age of Onset
1
2020
599
0.040
 Why?
Insulin Resistance
1
2020
683
0.030
 Why?
Prospective Studies
1
2023
6491
0.020
 Why?
Anti-Bacterial Agents
1
2023
2550
0.020
 Why?
Cohort Studies
1
2020
5100
0.020
 Why?
Risk Factors
1
2024
11022
0.020
 Why?
Retrospective Studies
1
2023
17764
0.010
 Why?
United States
1
2020
11852
0.010
 Why?
MERJANEH's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_